Roche’s Kadcyla, Bayer’s Xofigo Head Latest Positive Opinions In Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
GSK’s once-daily combination inhaler Relvar Ellipta along with J&J’s diabetes therapy Invokana, Novo Nordisk’s hemophilia therapy NovoEight and Gilead HIV therapy Vitekta complete the list of six new medicines recommended for approval by the CHMP, Europe’s top scientific advisory panel.